Product Images Oxbryta
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Oxbryta NDC 72786-111 by Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - oxbryta 01
Figure 1 - oxbryta 02
PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - oxbryta 03
oxbryta 04
oxbryta 05
oxbryta 06
oxbryta 07
oxbryta 08
oxbryta 09
oxbryta 10
Oxbryta is a tablet medication with each tablet containing 500mg of voxelotor. It is vital to swallow the tablets whole and not to crush, cut or chew them. The dosage of Oxbryta should be referred to the prescribing information. The medication should be stored at 20°C to 30°C (68°F to 86°F) and should not be used if the safety seal under the cap is broken. This medication is manufactured and distributed by Global Blood Therapeutics.*
oxbryta 11
Reonly Oxbryta is a medication available in tablet form with each tablet containing 300mg of voxelotor. The tablets must be dissolved in clear liquid before ingestion and should not be chewed or swallowed whole. The recommended dosage is available in the prescribing information. It should be stored in a place with a temperature range of 20°C to 30°C (68°F to 86°F). The medication should not be used if the safety seal under the cap is broken or missing. Reonly Oxbryta is manufactured for Global Blood Therapeutics Inc. and is not suitable for children. NDC 72786-111-03 and GTIN 00372786111035 are the identification codes for the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.